Network origin in Lida Pacaud first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
Novartis International AG
 Novartis International AG Pharmaceuticals: MajorHealth Technology Novartis International AG manages the Novartis Group. It provides administrative, financial, legal, and technical services. It also offers scientific consultation to the Group. The company was founded on December 13, 1989 and is headquartered in Basel, Switzerland.
17
| Subsidiary | Pharmaceuticals: Major | 17 |
| Public Company | Pharmaceuticals: Major | 12 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Lida Pacaud via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| NOVARTIS AG | Pharmaceuticals: Major | Director/Board Member Director/Board Member Corporate Officer/Principal Compliance Officer Chief Executive Officer | |
| The University of Chicago | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
Novartis Institutes for Biomedical Research, Inc.
 Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Director/Board Member Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Duke University
 Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Doctorate Degree Doctorate Degree Corporate Officer/Principal | |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Chief Executive Officer Director of Finance/CFO | |
| Nanjing University | College/University | Graduate Degree Undergraduate Degree | |
Novartis Pharma Schweiz AG
 Novartis Pharma Schweiz AG Miscellaneous Commercial ServicesCommercial Services Novartis Pharma Schweiz AG engages in the marketing and distribution of pharmaceutical, chemical, and medical products of the Novartis group. Its products are used in the treatment of diseases in the areas of neurology, immunology, dermatology, ophthalmology, cardiology, and oncology. The company was founded on December 10, 1986 and is headquartered in Rotkreuz, Switzerland. | Miscellaneous Commercial Services | Corporate Officer/Principal Director of Finance/CFO | |
| Novartis Pharma BV | Corporate Officer/Principal Chief Executive Officer | ||
Novartis Pharma AG
 Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Novartis Pharma AG engages in the research in as well as the production and distribution of pharmaceutical, chemical, medical, and biotechnological products. It also provides related services. The company was founded on October 25, 1989 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Corporate Officer/Principal General Counsel | |
| University of Antwerp | College/University | Graduate Degree Graduate Degree | |
| AMGEN INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| MARKER THERAPEUTICS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| New York University | College/University | Doctorate Degree | |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Director/Board Member | |
| Robert Wood Johnson Medical School | College/University | Doctorate Degree | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal | |
| INDIVIOR PLC | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| SPRUCE BIOSCIENCES, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
Aventis Pharmaceuticals, Inc.
 Aventis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aventis Pharmaceuticals, Inc. develops, manufactures and markets pharmaceutical products. The company was founded in 1950 and is headquartered in Bridgewater, NJ. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| The Royal College of Physicians | College/University | Corporate Officer/Principal | |
| Pontificia Universidad Católica Argentina | College/University | Graduate Degree | |
Novartis Australia Pty Ltd.
 Novartis Australia Pty Ltd. BiotechnologyHealth Technology Novartis Australia Pty Ltd. engages in the marketing and wholesale of pharmaceutical products in Australia. The company is headquartered in North Ryde, Australia. | Biotechnology | Corporate Officer/Principal | |
| COHERUS BIOSCIENCES, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| Charing Cross Hospital Medical School | College/University | Graduate Degree | |
| Xi'an Jiaotong University | College/University | Doctorate Degree | |
| Hiroshima University | College/University | Graduate Degree | |
| SHATTUCK LABS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| GSK PLC | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
BioCrossroads
 BioCrossroads Investment ManagersFinance BioCrossroads (BioCrossroads) is a venture capital firm founded in 2002. The firm is headquartered in Indianapolis, Indiana. | Investment Managers | Director/Board Member | |
Leica Microsystems GmbH
 Leica Microsystems GmbH Electronic ComponentsElectronic Technology Leica Microsystems GmbH develops and manufactures high precision optical systems. Its products includes microscopes and imaging solutions, modular microscopers for needs. The company was founded in 1849 and is headquartered in Wetzlar, Germany. | Electronic Components | Compliance Officer | |
Priothera Ltd.
 Priothera Ltd. BiotechnologyHealth Technology Priothera Ltd. engages in the development of orally delivered sphingosine-1-phosphate (S1P) receptor modulators for hematological malignancies. The company was founded by Florent Gros, Shaval Patel, and Brice Suire in 2020 and is headquartered in Dublin, Ireland. | Biotechnology | Founder | |
| African Parks Network | Chairman | ||
Novartis Korea Co., Ltd.
 Novartis Korea Co., Ltd. Drugstore ChainsRetail Trade Novartis Korea Ltd. engages in the manufacture and sale of pharmaceutical products. The company was founded on September 20, 1984 and is headquartered in Seoul, South Korea. | Drugstore Chains | Chief Executive Officer | |
Inflazome Ltd.
 Inflazome Ltd. Pharmaceuticals: MajorHealth Technology Inflazome Ltd. engages in developing therapeutic medicines for inflammatory diseases. It manufactures and supplies medicines for muckle wells, type 2 diabetes, atherosclerosis, hypertension, gout, osteoarthritis, rheumatoid arthritis, Parkinson, Alzheimer, and multiple sclerosis. The company was founded by Matthew A. Cooper and Luke O'Neill in 2016 and is headquartered in Dublin, Ireland. | Pharmaceuticals: Major | Director/Board Member | |
Kanyos Bio, Inc.
 Kanyos Bio, Inc. Pharmaceuticals: MajorHealth Technology Kanyos Bio, Inc. engages in the provision of immune tolerance technology solutions. It develops antigen-specific for treatment of type-1 diabetes and celiac disease. The company was founded by Jeffrey Hubbell, Stephan Kontos, Oscar Buset, Kristen M. Lorentz, and David A. Lowin in 2015 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member | |
Novartis Vaccines & Diagnostics, Inc.
 Novartis Vaccines & Diagnostics, Inc. Pharmaceuticals: MajorHealth Technology Novartis Vaccines & Diagnostics, Inc. manufactures and markets health care and nutritional products. The company was founded in 1986 and is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | President | |
Anokion SA
 Anokion SA Medical/Nursing ServicesHealth Services Anokion SA provides technology for retraining white blood cells to induce therapeutic immune tolerance. The firm?s approach to antigen-specific immune tolerance can be translated to virtually any protein in numerous clinical indications. The company was founded by Jerffery Hubbell, Melody Swartz, Stephan Kontos, Oscar Buset, Kristen M. Lorentz and David A. Lowin and is headquartered in Ecublens, Switzerland. | Medical/Nursing Services | Director/Board Member | |
| UCB | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| The University of North Carolina at Chapel Hill | College/University | Corporate Officer/Principal | |
| Duke University Medical Center | College/University | Corporate Officer/Principal | |
| RA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Quell Therapeutics Ltd.
 Quell Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Quell Therapeutics Ltd. is a London-based biotechnology company, which develops immune cell therapies to target transplant rejection, autoimmune and inflammatory diseases. It develops engineered T regulatory cell therapies for a variety of non-cancer targets. The company was founded on March 19, 2019 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
Sandoz International GmbH
 Sandoz International GmbH Pharmaceuticals: GenericHealth Technology Sandoz International GmbH develops and manufactures generic pharmaceuticals. It produces finished dosage forms of such off-patent drugs as diabetes treatment Glucophage, GERD drug Prilosec, and cholesterol. The company was founded in 1996 and is headquartered in Holzkirchen, Austria. | Pharmaceuticals: Generic | Corporate Officer/Principal | |
Semma Therapeutics, Inc.
 Semma Therapeutics, Inc. BiotechnologyHealth Technology Semma Therapeutics, Inc. develops transformative therapies for patients who currently depend on insulin injections. It focuses on combining proprietary cells with a state-of-the-art device to provide a true replacement for the missing beta cells in a diabetic patient without immunosuppression. The company was founded by Robert A. Millman, Walter A. Blättler, Felicia Pagliuca, Jeff Imbaro and Douglas A. Melton in 2015 and is headquartered in Cambridge, MA. | Biotechnology | Chief Executive Officer | |
| ADICET BIO, INC. | Pharmaceuticals: Major | Director/Board Member | |
| VERTEX PHARMACEUTICALS INCORPORATED | Pharmaceuticals: Major | Corporate Officer/Principal | |
| University of Sassari | College/University | Doctorate Degree |
Statistics
International
| United States | 27 |
| Switzerland | 5 |
| United Kingdom | 5 |
| China | 3 |
| Belgium | 3 |
Sectoral
| Health Technology | 28 |
| Consumer Services | 15 |
| Commercial Services | 3 |
| Finance | 2 |
| Electronic Technology | 2 |
Operational
| Director/Board Member | 81 |
| Corporate Officer/Principal | 53 |
| Chief Tech/Sci/R&D Officer | 25 |
| Independent Dir/Board Member | 22 |
| Chief Executive Officer | 19 |
Most connected contacts
| Insiders | |
|---|---|
| Fang Liang Zhang | 24 |
| Liz Doherty | 20 |
| Tomas Jan Heyman | 18 |
| Vasant Narasimhan | 17 |
| Peter Piot | 14 |
| Eric Cornut | 14 |
| Ton Büchner | 14 |
| Andrin Oswald | 12 |
| Dhavalkumar Patel | 12 |
| Rosh Dias | 10 |
| Marcela A. Kirberger | 9 |
| Bastiano Sanna | 8 |
| Li Mao | 8 |
| Simon Cooper | 8 |
| Philippe Deecke | 7 |
- Stock Market
- Insiders
- Lida Pacaud
- Company connections
